News search

E.g., 28/06/2026
E.g., 28/06/2026
from left to right: Haruka Toda, Irene García Martín, María Maeve Soto Pérez, Alexia Ramos Gutiérrez, Mirian Nieto Delgado, Demetrio Julián Santiago Castillo, Paola Rocío Riveros Rodríguez, Lucía Pilar López Palomar, Andrés Redondo Rodríguez, Jorge García Quintanilla, Marinela Couselo Seijas, David Filgueiras Rama, and José Jalife.
Research
28 May 2026

The findings, published in Cardiovascular Research, show that the right ventricle has greater metabolic resilience than the left during cardiac arrest caused by ventricular fibrillation.

Annalaura Mastrangelo
Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
Research
22 May 2026

CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

Francesco Costa
Jennifer Davis
Faseeha Ayaz
Research
30 Apr 2026

Faseeha Ayaz, senior Editor Nature Communications, Springer Nature

Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
Research
23 Apr 2026

Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht

Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
Research
21 Apr 2026

The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

Michael Reth profesor de Inmunología Molecular en la Universidad de Friburgo